Sep 24 2009
EFT BioTech Holdings, Inc. (PINKSHEETS: EFTB) (FRANKFURT: 9EF), a proprietary e-commerce solutions company providing "Made in the USA" health, beauty and nutriceutical products under the EFT brand to its affiliate member network, boasting almost one million members strong, announced its upcoming schedule for executive management attendance at new affiliate rallies in Asia.
According to existing affiliate reservations reports, the executive management team will host new membership recruiting functions for thousands of attendees. These product introduction and affiliate meetings are part of the major and ongoing core sales drives each year. This two-week trip will encompass several stops in Asia including some of the newer markets, like North and South Vietnam.
Jack Qin, President and CEO, stated, "Of all of the activities that we support during the year to increase sales, this is one of our most effective methods. The power of personal presence by management and the excitement for the products we sell adds both to our affiliate base as well to our bottom line sales. We anticipate being in front of many audiences with thousands of people who will join our organization and become part of our team."
Recently joining the EFT organization at the home office in California is Edward Carter, longtime investment professional. His duties include coordinating shareholder relations for the 28,000+ EFT shareholders and liaison for corporate communication. According to Ed Carter, who will also be in attendance in Asia, "Many of our Asian affiliate members have reported opening up new on-line brokerage accounts in the USA. Part of my presence at the upcoming meeting is to clarify and answer general questions from existing members as to what the process entails in opening an account and to ensure all aspects of SEC compliance relative to such activities."
In addition to attending the various rallies scheduled, management also intends to meet with Hong Kong stock exchange officials to discuss various additional listing options in addition to the pending OTCBB listing upgrade in the US.
Source:
EFT BioTech Holdings, Inc.